Responses of the lung to toxic injury. by Witschi, H
Environmental Health Perspectives
Vol. 85, pp. 5-13, 1990
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by Hanspeter Witschi*
Analysis oftoxic lungdamage may focus onthe offending agentanddefine patterns ofbioactivation
and interactions withthe target tissues. It may also focus on a study ofthe biological response. While
itwasoriginallythoughtthatcellproliferation, particularly TypeIIepithelialcellproliferation following
lunginjury, wasacommonevent, itnowhasbecome obvious that onoccasionproliferation occurs only
late after the initial lung damage. Also Type II cell proliferation can occur in the absence ofalveolar
TypeIcelldamage. Delayedreepithelialization ofthealveolarsurface mayleadto pulmonary fibrosis.
Toxicologicalinteractions oftencanbebestrecognizedanddefinedbytheextensivelesionsthatresult
fromconcomitantorsequentialexposuretosuchtoxicagentsasozoneandacidicaerosolsoranticancer
drugs andoxygen. A correlation ofcellproliferation andtumor development in mouselung has shown
that target cell hyperplasia is not a necessary prerequisite for enhanced tumor development. On the
other hand, oxygen-induced proliferation ofthe neuroendocrine cell population results in the short-
term development ofneuroendocrine lung cell cancer in hamsters. While it is possible to draw some
conclusionsfromananalysisofthelungresponse totoxicinjury, predictions made from suchknowledge
are sometimes, but not necessarily always, correct.
Introduction
Airborne and bloodborne chemicals may cause toxic
lung damage. It is the goal of experimental toxicology
to understand the possible underlying mechanisms. A
mechanism may be defined as "the fundamental or
physical processinvolvedin orresponsiblefor anaction,
reaction, orothernaturalphenomenon(asorganicevolu-
tion)" (1). Itiscertainly fairto saythat weknow agreat
deal about mechanisms which underlie what can be
defined asactionsintoxiclungdamage. Themetabolism
of many drugs has been elucidated in great detail dur-
ingthe past 10 to 15 years. The roles ofbioactivation in
toxicity, conversion from proximate to ultimate toxins,
andpathwaysofdetoxificationandofprotection are well
knownformanychemicals, includingcarcinogens(2,3).
Andformanyofthe sameagents, informationisavailable
onthebiochemical changestheyproduce in lungtissue
or in isolated lung cells (4).
We know less about mechanisms underlying what
we may call reactions in the pathogenesis oftoxic lung
damage. Quite often we are unable to link a specific
and mechanisticallydefinedactionto aspecificand pre-
dictable reaction or tissue response. A recent and
excellent analysis of our present knowledge of lung
damage caused by chemicals stresses two points (5).
Apparently similar mechanisms leading to cell damage
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will not necessarily always produce the same ultimate
tissue lesions in the lungs of different species. On the
otherhand, similarlesionsareoftentheresultofinitially
quite different mechanisms. The second point is that
studies onthepulmonarytoxicity ofdrugsorchemicals
willeventuallybe remembered notbecause ofthe toxi-
cologic, economic, or social consequences of the
chemical, but because of the concepts developed
through their study (5).
The first point made by Smith and Nemery (5)
clearly emphasizesthatwefaceconsiderablegapsinour
knowledge whenwetrytounderstandmechanisms that
determine the response orreaction ofthe lung to toxic
injury. Perhaps we should, for the time being, adopt a
somewhat different approach to what constitutes a
mechanism. We may define it as an initial event or as a
sequence of consecutive events which will produce a
similarbiologicalresponseregardlessof howtheprocess
was initiated (6). This implies that in our attempts to
understand toxic lunginjury and to develop broad con-
cepts, we should focus as much on the tissue response
aswe usuallyfocusonthemetabolic fate ofthe offend-
ingchemicals. Wealsomightconsiderthatamechanism
need not be exclusively an event that is understood at
the chemical, i.e., molecular level. A mechanism may
also consist ofeventsthat canbe described at different
levels. What a mechanism eventually should give us is
thecapability topredictthe initiationandtheevolution
of a process leading to acute or chronic disease. In the
following, the history and success of a few attempts to
determinemechanisms oflungdiseasealongtheselines
are reviewed and analyzed critically.H. WITSCHI
Cell Proliferation As a Common Lung
Response to Toxic Injury
A review of some of the literature available 15 to 20
years ago showed that in many instances toxic lung
irnury appeared tofollow asomewhat monotonousand,
more importantly, predictable pattern (7). The cells
apparently mostvulnerable to manytoxic agentsinthe
lung are the Type I alveolar epithelial cells, cells which
cover about 95% ofthe alveolar surface. Theirpeculiar
shape and localization within the alveolar walls pre-
cludesfurtherdivision(8). Once damaged, they cannot
be replaced by a division ofadjacent undamaged sister
cells. To repair defects in the alveolar epithelium, the
lunghastorely on asecondcelltype, theTypeIIalveolar
epithelial cells. These cells areoften calledthestem cells
ofthealveolarepithelium. Theybegintodivideandwill
eventually assumeboththeshapeandthefunctionalrole
of the Type I epithelial cells. Transition of Type II into
Type I cells has been documented indirectly with
autoradiography (9) and directly with morphologic
methods (10).
Although other cells of the alveolar wall such as
interstitial cells and capillary endothelial cells
undergo division following toxic lung injury, the main
emphasis in the analysis of cell proliferation following
lung damage was usually placed on the changes occur-
ring in the epithelial cell population. Type II cell
division as a response to injury of Type I cells remains
a key element in our appraisal on how damaged lung
repairs structureandfunction. Forexample, itisbelieved
that agents thatproduce only Type Icell damage usual-
ly leave only mild ormoderate permanent lunglesions.
Examples might be the antioxidant butylated hydro-
xytoluene(BHT)and manyofthe commonairpollutants.
On the other hand, chemicals that have the capability
to damage and destroy bothType I and Type II cells are
much more harmfulandoftenleadtofatallunglesions.
Examples might be the herbicide paraquat and the
antineoplastic drug bleomycin. Maintaining a healthy
population of Type II alveolar cells seems to be a pre-
requisite forthelungtodefenditselfsuccessfullyagainst
chemical injury (11).
In 1978 a small but carefully performed study estab-
lished adirectrelationshipbetweentheextentofdamage
tothe alveolarType I epithelium, which wasmeasured
by quantitative morphometry, and the subsequent
proliferation of the Type II cell population, which was
measured by the incorporation of radiolabeled thy-
midine into cellnuclei(12). Thisparticularpieceofwork
turned outtoberatherinfluential. Oncetheconcept was
established and accepted that Type II cell proliferation
was proportional to the initial lung injury, toxic lung
damage was quite often detected and analyzed by the
simple expedient of measuring the incorporation of
radiolabeled thymidine into total pulmonary DNA
(13,14). The biochemical procedure has the advantage
ofbeingquantitative, allowingresearcherstostudymany
more tissue samples in a shorter time than would be
possible with morphometric or autoradiographic
methods. It was, of course, well recognized that a
measurementofthymidineincorporationintototalDNA
couldbynomeansprovide accurate dataonTypeIIcell
proliferation; rather, it would reflect overall DNA syn-
thesis in the entire lung cell population. Since
autoradiographicstudiesdidsuggestthatthe prominent
cellpopulationproliferatingafterlunginjury wasindeed
the Type II cell population, representing up to 70% of
all dividing lung cells (15), the assumption was not
entirely unreasonable that a biochemical technique
woulddirectlyrelatetoreparativecellproliferationand,
therefore, to initial lung damage.
During the same time, several morphologic studies
reported an observation which seemed at first puz-
zling and contrary to the established knowledge about
findingincreasedcellproliferationinthelungsofanimals
exposed to various dusts and fumes without seeing
apparentlunglesionstoexplainthephenomenon. Such
observations were made in animals exposed to diesel
engineemissions, flyash, andmetaloxidedustsbelieved
tobedevoidofanybiologicalaction(16-18). Itwasnoted
in these experiments that there was usually a large in-
flux of inflammatory cells into the lung.
Insubsequentexperimentsitwasshownthat, indeed,
migration of inflammatory cells across the blood-air
barrierwassufficienttotriggeraproliferative response
in the alveolar epithelium (19). Mice were made
leukopenicbyinternalradiationwith89Srandchallenged
withanintratrachealinstillationofbiologicallyinertcar-
bonparticles. Asexpected, theproliferative responseof
the lungs of leukopenic animals to carbon-which in
itself did not produce any lung damage-was con-
siderablylessthanitwasinthelungsofnormalanimals.
The hypothesis put forward was that inflammatory
cells passing between epithelial cells in the lung trig-
geredaroundofcelldivisioneitherbybreakingcontact
inhibition or by releasing specific growth factors. The
results ofthis experiment no longer allow us to equate
Type IIcellproliferation withType I celldamage under
all circumstances.
A second concept derived from analysis ofepithelial
cell proliferation following lung injury deals with the
development of fibrotic lung disease. In 1976 it was
suggested that in oxygen-damaged mouse lungs an un-
disturbed reepithelialization of the air-blood barrier
following the initial injury was necessary in order to
obtain proper healing (20). If too much toxic damage
to the alveolarType II cell population delayed or even
prevented the process, fibrosis developed.
Theoriginalmodelwasrecentlyrefined(21). Micewere
exposed to 95% oxygenfirst. Afterdifferentlengths of
exposure, lungdamage was assessed withmorphologic
and biochemical techniques. At the same time, lung
explants were prepared for further maintenance and
studyinculture. Theculturesmadeitpossibletofollow
preciselythe development orresolution ofthe oxygen-
inducedlesions. Inlungsthathadbeendamagedinvivo
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for 4 days and showed comparatively mild lesions, the
injury remained limited mostly to capillary endothelial
cells. Recovery afterremovalfromhyperoxi-a wasgood,
andinterstitial cellsdidnotshowexcessiveproliferative
activity.
In more seriously damaged lungs (6 days in oxygen)
there was marked toxicity to the epithelial cells, pre-
ventingthemfromrecovery. Underthesecircumstances,
theinterstitialcellpopulationstartedtoproliferate and
to produce substantially more collagen. Since the lung
explantscontained onlyveryfewalveolarmacrophages
orpolymorphonuclear cells, itwasconcludedthatthese
cellsdidlittletoinfluence the developinglesions. Severe
injury to and delayed repair ofthe alveolar epithelium
may thus give the underlying fibroblast population a
chance to overgrow and to produce abnormal amounts
of collagen, leading to the development of diffuse
interstitial pulmonary fibrosis.
Asimilarconclusiononthe criticalrolethatreepithe-
lizationplaysinadamagedlungwasreached withadif-
ferent experimental approach. Mouse lung is readily
damaged by the antioxidant BHT (15,21). Detailed cell
kinetic analysis showed that following initial damage
(widespread necrosis in the Type I epithelium and, to a
lesser extent, in the capillary endothelial cells),
there would follow, 2 to 4 days later, a burst ofType II
cellproliferation. Onlylaterinterstitialcellsandcapillary
endothelialcellsalsoproliferated. Whenmicewithlungs
damaged by BHT were exposed to an atmosphere of
100% oxygen, it was found that oxygen inhibited
pulmonary cell division only 2 or 4 days after BHT, but
not later(22). The conclusion drawn was that dividing
epithelial cellswould bemoresensitive tothecytotoxic
action of oxygen than would dividing interstitial cells.
It was speculated that interference with epithelial cell
regeneration might favor the development of fibrotic
changes in a damaged lung.
Evidence to support this hypothesis was found in
several experiments (23,24). When animals with BHT-
damaged lungs were exposed to hyperoxia during the
phase of epithelial cell proliferation, fibrosis devel-
oped. Inthemostseverelyalteredsepta, liningcellswere
often absent, and interstitial connective tissue fibers
wereexposeddirectly totheairspaces(25). Thefibrotic
changes persisted up to 1 year and included not only
excess collagen accumulation, but also changes in the
ratioofTypeItoTypeIIIcollagen(26). Themorphologic
changesseeninthelungsofmicetreated withBHTand
oxygen were quite similar to the lesions observed in
humanlungsafflictedwithidiopathicpulmonaryfibrosis
(25). On the other hand, when oxygen exposure was
delayeduntilepithelialrecovery waswellunderwayor
complete, no fibrosis developed (23).
Analysis of patterns of cell proliferation in the lung
helpedtoexamineanotherimportantquestion: Isthere
evidence that different species would respond differ-
ently to identical amounts of the same toxic agent?
Species differences in the response of lung to foreign
chemicals arewellknown. Forexample, hamstersseem
to be much more resistant to inhaled carcinogens and
other toxic agents than are most otherspecies (27,28),
and BHTdamages mouselungonly, but notthelungsof
otherspecies(14). Itis, ofcourse, possiblethatmanysuch
differences may be explained by the ways foreign
chemicals are handled. Differences in uptake by target
cells and tissues, in metabolism, detoxification mecha-
nisms, and elimination all might account for variations
in the biological response. Possibly there is also an in-
herent difference between different species in the
response of the lung tissue to toxic materials. The fact
thatratsaretheonlyspecieswhichcanbemadetolerant
to 100% oxygenbypreexposure to 85% oxygen appears
to support such a possibility (29).
Tb test the hypothesis directly, one would require an
agent that is handled by all species the same way and
canbeapplied instrictly comparable doses. Oxygen, of
course, is such an agent; it is presumably handled
the same way by all mammals. As far as comparable
doses are concerned, it could be argued that there can
hardlybeamorecomparabledosethantoexposeanimals
for identical lengths of time to 100% oxygen.
We exposed mice, rats, hamsters, and marmosets for
48 hr to an atmosphere of 100% oxygen (30). After
exposure, aminipumpfilledwithradiolabeledthymidine
wasimplanted IPorundertheskinoftherodent'sback.
One week later the animals were killed and autoradio-
graphsoftheirlungswereprepared. Analysisofpatterns
ofcellproliferation was used to examine how the lungs
dealt with recovery from oxygen toxicity.
We did find substantial differences between the four
species, both quantitatively and qualitatively. The
greatest lung damage occurred in rats and the least in
hamsters and marmosets. In rats, the predominant cell
typetoproliferatefollowinglunginjurywasthecapillary
endothelial cells. In mice and marmosets recovery was
characterized by an epithelial proliferative pattern.
Whenmiceappearingtobelesssensitivetooxygenthan
rats were exposed for longer than 48 hr to oxygen, an
increase in overall cell proliferation was observed, but
there wasnochangeinthepatternofcellproliferation.
Again, the predominant response was epithelial.
Theexperimentclearlyhighlightsinherentspeciesdif-
ferences in what most likely is an identical and com-
parable insult to the lung. It also raises the question to
whatextentstudieswithratlungsarerepresentativeof
oxygentoxicityinman. The recovery patterns found in
mice and marmosets appeared to resemble much more
what we know ofoxygen toxicity in human lungs than
did findings made in rats (31).
Toxicologic Interactions in the
Pathogenesis of Lung Injury
Exposure of the lung to two or more chemicals may
occur in heavily polluted atmospheres or perhaps in
critical care medicine. On occasion, this results in lung
damagethatismoreseriousthanmightbeexpectedfrom
our knowledge of the actions of single chemicals (32).
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The occurrence of interactions is often difficult to
predict. Qualitative and quantitative analysis of the
responses of the lung is practically the only way to
recognize toxicological interactions.
It has been known for some time that exposure of
paraquat-treated rats tohigh concentrations ofoxygen
intheinspiredairismuchmorelethalthanthatexpected
fromexposingratstoparaquataloneortooxygenalone
(33). The question might be asked whether paraquat
enhances oxygen toxicity orwhether oxygen enhances
paraquattoxicity. Theanswertothisquestioncamefrom
adetailed morphologic analysisofthelungdamagepro-
duced by the combined two agents (34). The cell type
most severely damaged was the 'Iype II alveolar cells.
Paraquat is one of the compounds that causes perma-
nentdamagetothe IypeIIcellpopulation. Oxygenthus
appeared toenhance paraquattoxicity. Ifparaquathad
enhanced oxygen toxicity in rat lung, then one might
haveexpectedtofinddamageduetoaparaquat-oxygen
interaction predominantly in the capillary endothelial
cells-theprimarycellsofoxygentoxicityinratlung.This
example shows how a study of the biological response
may, indeed, giveussomemechanisticclues. Atthesame
timeitremainspuzzlingwhyabiochemicalmeasurement
indicative ofacuteparaquattoxicityfailedtopickupan
interactionbetweentheherbicide andoxygen. NADPH
depletion maybeakeyelement inpulmonaryparaquat
toxicity(35). Yet, in the lungs ofratstreated with para-
quat, theeffectsofinhaledoxygenonthereducingstatus
of the NAPD/NADPH system remained the same as in
animals kept in air (36).
Other types of chemical interactions are less well
understood, although the biological response has been
extensively investigated. The acute pulmonary toxi-
city of certain anticancer drugs such as bleomycin or
cyclophosphamide is enhanced by exposing animals to
hyperoxia(3?). It is possible, although not proven, that
similar events may occur in man. Originally it was
thought that the mechanism responsible for this par-
ticular interaction was similar to the one postulated
for the interaction between BHT and oxygen: that
oxygen would interfere with reepithelialization follow-
ingtheinitialinjury. Itisnolongercertainwhetherthis is
indeed the case withoxygen-mediated amplificationof
bleomycin orcyclophosphamide-induced lungdamage.
Oxygen is quite effective in potentiating lung damage
if given early after the anticancer drugs (37). As short
an exposure time of 12 hr in 80% oxygen will produce
100% mortality within 72 to 96 hr in hamsters treated
withadoseof0.5unitsofbleomycinintratracheally(38).
Epithelialcellproliferation, ontheotherhand, isdelayed
until 10to 14daysaftercyclophosphamideorbleomycin
administration(39). Itwouldthusappearthatpotentia-
tion oflung damage occurs because ofa direct interac-
tion between the anticancer drug and oxygen, rather
thanbecauseoxygeninterfereswithproperrepairofthe
lesion, althoughinterference withearlyrepairprocesses
cannot be excluded. A general influx and proliferation
of alveolar macrophages might be an additional factor
(38). Possibly oxygen also amplifies the generation of
hydroxyl radicals, an event thought to be critical in
bleomycin pulmonary toxicity. On the other hand, two
observations are somewhat difficult to reconcile with
simple amplification of lung injury. One is that in
hamsters given a single intratracheal instillation of
bleomycin and then exposed for 24 hr to oxygen,
pulmonary edema develops only some 72 hr later (38).
The reason for this delayed response is unclear. The
second phenomenon is the continuing development of
lung damage (40). Treatment of rats with a combina-
tionofbleomycinandoxygenproducesalunglesionthat
has all the hallmarks of progressive interstitial
pulmonary fibrosis.
A somewhat similarobservation wasmade in astudy
that examined the long-term effects ofasingle admini-
strationofcyclophosphamide (41). Itwasfoundthattotal
lung collagen content increased progressively over a
1-yearperiod. Theexactmechanismsresponsibleforthis
progressing lesion are not understood. The two obser-
vationsdopointouttheneedforabetter understanding
oftheinterrelationshipsbetween acutelesionsandtheir
eventualtransformation into chronic events. Ofpartic-
ularinterestistheobservationthatchronic-progressive
lesions may result from a single episode of exposure to
one or several drugs; why the disease process, once
initiated, seemstosustainitselfoveraperiod ofweeks
or months is obviously of considerable interest.
Examination ofthe biological response has also been
critically important in analyzing the consequences of
exposuretomorethanoneairpollutant. Itisobviousthat
inanyheavilypollutedatmosphere, manynoxiousagents
are present. Most experimental research on acute and
chronic health effects of air pollutants deals with
exposuretoonecompoundatatime(42). Whilethismay
bejustifiable, itshould nevertheless be recognized that
a combined exposure to several pollutants may, on
occasion, cause more damage than might be expected
fromastudyoftheeffectsofsinglecompounds. Several
yearsago it wasfound thatexposure to SO2 andseveral
particulate aerosolswouldproduce anexacerbated air-
way hypersensitivity, compared to that expected from
the known effects of the individual agents alone (43).
More recently it has been shown that a concomitant
exposuretothecommonairpollutantozoneandtoacidic
aerosols, particularly H2SO4, will greatly enhance the
rate ofcollagen synthesis inthe lung(44,45). Ofpartic-
ularimportance wasthe observation that suchinterac-
tionsdidoccuratlevelsofacidicaerosoland ozonethat
are close or identical to conditions encountered in the
realworld. Itmustbe notedthat, atpresent, airquality
standardsforairpollutants are setand regulatedbased
on data pertaining to individual chemicals only. The
question must be asked whether this approach will be
sufficient to deal with the possibility of interactions.
Again, it must be pointed out that only the study of
the biological response, the apparent synthesis rate of
pulmonarycollagen, providedevidencethatpotentially
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important interactions between ozone and an acidic
aerosol could be of practical importance. As far as
mechanisms are concerned, there is only speculation.
A reasonable assumption is that inhalation ofan acidic
aerosol alters the pH within the tracheobronchial tree
and perhaps at the centroacinar target sites for ozone.
Achangeinthemicroenvironmentmightallowforlonger
half-lives ofactivemolecularspeciesinvolved inoxidant
damage, thuscreatingthepotentialforanexacerbation
of lesions.
Theproblemofinteractionsbecomesevenmorecom-
plexwhenwedealwithmultichemicalexposure. Itisnot
unreasonable to assume that exposure to complexmix-
tures can, on occasion, result in biologically significant
toxicological interactions. It is, of course, impossible to
study the toxicity of all single ingredients in such com-
plexmixtures as, forexample, represented by cigarette
smoke or diesel engine exhaust. In order to assess tox-
icity, the only practical way is to rely on the biological
response. This approach is not always rewarding. Al-
though there is certainly overwhelming epidemiologi-
calevidence to link cigarette smokingto lungcancerin
man, onlycomparatively fewanimalinhalation studies
have shown a similar correlation (46). The production
of lung tumors in rats, mice, or hamsters by inhalation
oftobacco smoke has proved to be a difficult and often
elusive endeavor. As far as diesel engine emissions are
concerned, numerous in vitroshort-term assaysforcar-
cinogenicity suggestthepresence ofpotentcarcinogens
and mutagens associated with diesel exhaust particles.
Studieswithwholeanimalshave shownthatprolonged
exposure to diesel engine emissions produces lung
tumorsinrats(27,47). Itwaspointedoutrepeatedlythat
tumordevelopment mightbe aconsequence ofparticle
overload of the lungs with a resulting decrease in pul-
monaryclearance(48). Itwasstressedthatthisoverload
in the end might be responsible for the carcinogenic
actionofdieselemissionparticles. Thisisaninteresting
hypothesis. Thequestionaskedmaybe: Whatare, under
less stressing and therefore nontumorigenic conditions
ofexposure, the ultimate metabolicfate, andbiological
effects ofallthese compounds that are associated with
diesel exhaust particles and which show considerable
mutagenic activity in appropriate short-term assays?
Modification of Tumor Development
in the Lung
We have earlier made atentative attempt to broaden
the definition ofmechanisms. A mechanism mightbe a
sequence of consecutive events that yield a similar
biological response, regardless of how the process was
initiated. Several experimental investigations on the
biologicalbehavioroflungtumorsinmicewereprecisely
undertaken because it was thought such a mechanism
wasknownand, therefore, mightproduceananticipated
development. It is interesting to note that more often
than not, the prediction made originally turned out to
be correct, although quite often for the wrong reason.
Inacomprehensive review on the mechanism ofpro-
moters in carcinogenesis, Boutwell in 1974 (49) con-
cluded that the capability to produce epithelial cell
proliferation wasacriticalpropertyofmouse skintumor
promoters. [It also was pointed out that not all agents
capable of producing skin cell proliferation would be
tumorpromoters(49).] Atthesametime, practically no
evidence was available that showed two-stage carcino-
genesis existing in organs other than mouse skin.
Lung tumors in mice are believed to originate from
Type II alveolar epithelial cells (50), although some of
themmightalsobeofClaracellorigin(51). Thequestion
for the time being is open to discussion (52). Ten years
agothefollowingpredictionwasmade. Itwasknownthat
manytumorsinmouselungwereTypeIIcelltumors, and
thattumor-promoting agentswere able toproduce cell
proliferationinmouseskin. Whenitwas foundthatBHT
would stimulate proliferation of Type II cells in mouse
lung, itwaspostulatedthatthissituationmightsomehow
fulfillthecriteriaputforwardaboveformechanisms. In
otherwords, BHTshouldbecapableofpromotingtumor
development in mouse lung (53).
In a series of experiments it was found that in strain
A or Swiss-Webster mice treated first with a carcino-
gen such as urethan or methylcholanthrene, the sub-
sequent administration of BHT (by IP injections or
given in the food) would greatly increase the number
of lung tumors (54). BHT was found to have such an
effect even ifgivenforthe firsttime 5 monthsafterthe
carcinogen (55). On the other hand, BHT was not
effective in increasingtumoryield inmice treated with
subcarcinogenic doses of a carcinogen, and it may be
questioned whether the BHT-lung tumor system rigor-
ouslyfulfillsallcriteriausuallyappliedtothemouseskin
tumorsystem. Nevertheless, underappropriate experi-
mentalconditionsBHTenhancestumordevelopmentin
mouse lung and also in several other organs such as
mouse liverand colon; rat liver, colon, urinarybladder,
forestomach, andthyroid; andinseveralin vitrosystems
(56).
If the underlying mechanism for enhanced tumor
development in mouse lung was the induction of
repeated Type II cellproliferation inthe lung, then two
morepredictionsshouldfollow. Bothofthesepredictions
could be and were tested in appropriate experiments.
Both predictions also proved to be wrong.
Several agents other than BHT were used to produce
alveolar Type II cell proliferation in mouse lung. They
allshouldhaveenhancedtumordevelopment. Intermit-
tentexposureofmicetreatedwithacarcinogento 100%
oxygen or injections of methylcyclopentadienyl
manganese tricarbonyl (MMT) produced Type II cell
proliferation, but they had no enhancing effect on
tumor development (57). Recently it was suggested
that glycerol, givenataconcentrationof5% inthedrink-
ingwater, wouldproduce hypertrophy and hyperplasia
oftheClaracellpopulationinthelungsofmaleddYmice
(58). Presumably, through this effect glycerol would
enhancetumordevelopmentinmouselung(59). Unfor-
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tunately, the response to glycerol appears to be unique
to the ddY mouse. In our own experiments with A/J or
Swiss-Webstermicewedidnot obtainanyevidencethat
glycerolwouldincreasealveolarorbronchiolarcellpro-
liferation or would enhance tumor development in
mouse lung and liver or rat liver (60).
It also was not possible to demonstrate unequivo-
cally that diffuse alveolar Type II cell hyperplasia was
a necessary prerequisite for enhanced tumor develop-
mentinmouselung. Twoobservationsweremade: First,
in our hands, the minimum number of BHT injections
needed to enhance tumor development are four. Yet, it
was found that after only two injections of BHT, mice
no longer responded with increased cell proliferation;
somehowtheanimalsappeartobecomeresistanttofur-
ther BHTtoxicity(57). Second, the damagingeffects of
BHTonlungtissuecouldbepreventedbymixed-function
oxidaseinhibitors(14). Asaconsequence, cellprolifera-
tion was prevented. However, tumor development still
was enhanced despite the absence of diffuse cell
hyperplasia in the lung. A detailed analysis of the
phenomenon showed that, indeed, it is entirely possi-
ble to separate enhanced tumordevelopment from dif-
fuse alveolar cell hyperplasia in the lung; the two
phenomena are not interdependent (61).
Sustained exposure to oxygen is able to elicit a con-
tinuing cell proliferation in the TIype II cell population
ofthe lungtwo to fourtimes overbasal rate (62). Thus,
one might expect that such an event would increase
tumordevelopmentinthelung, shouldcellproliferation
be such a crucial event in carcinogenesis. It could even
bespeculated thathyperoxiamightbedoublyeffective.
Underhyperoxicconditionsthere couldconceivably oc-
curanincreasedproductionandfluxofreactiveoxygen
species in the lungs of exposed mice. Reactive oxygen
speciesarebelievedtobeofcrucialimportanceintumor
promotion (63,64). However, in several experiments it
wasshownthatchronichyperoxia, ratherthanenhanc-
ingtumordevelopment, severely curtails tumorforma-
tion in mouse lung-even in the continued presence of
anactiveproliferativeresponseinthelypeHcellpopula-
tion and an increased activity of pulmonary ornithine
decarboxylase, believed to be a hallmark of tumorpro-
motion (62,65). It has not been possible to apply some
mechanisticconsiderations developedformouseskinto
the mouse lung tumor system.
Although cellhyperplasia does not appear necessary
to enhance the development oflungtumors in animals
afterexposure toacarcinogen, itmightbeimportantto
explain the development of spontaneously occurring
lungtumorsinmice. Agood correlation hasbeenfound
between ratesofbasalType IIcellproliferation andthe
apparentsensitivity ofvariousmousestrainstodevelop
spontaneouslyoccurringlungtumors(66). Andalthough
both oxygen(62) orozone(67) inhibit the development
of chemically induced tumors in mice pretreated with
a carcinogen, both gases increase the average number
oftumors and the percentage oftumor-bearing indivi-
duals in mice not knowingly exposed to a carcinogenic
agent(62,67,68). This, ofcourse, couldimplybothozone
or oxygen as pulmonary carcinogens, at least in mice.
There is an alternative explanation that would link
Type II cell proliferation to tumor development occur-
ringinsensitivemousestrains andalsoinmiceexposed
to ozone or oxygen. An increased number of dividing
cells would expand the cell population at risk (the risk
currently being unidentified) or place a continually
dividingcellpopulation at higher risk to undergo spon-
taneous transformation.
'lb explain the decreased number oftumors found in
animals pretreated with a carcinogen and then ex-
posed to ozone or to oxygen, another assumption is
needed. Oxygen appears to have high cytotoxicity for
newly transformed tumor cells in mouse lung, and the
gasappearstobecapableofpreventingindividualtumor
cellsorsmallclustersoftransformedcellsfromgrowing
intovisibletumors(62). Ifthisistrue, oxygenshouldpre-
vent tumor development in other species.
Tb test this hypothesis, rats received a single intra-
tracheal instillation of methylcholanthrene at a dose
known to produce, within a few weeks, multiple squa-
mous cell carcinomas in the lung. Exposure of such
animalstoanatmosphere of70% orevenof40% oxygen
dramaticallyreducedtumorformation(65). Thepercen-
tageoftumor-bearing ratsinthe oxygengroup wasless
thanhalfofthatfoundincontrols(wherepracticallyall
animals developed squamous cell carcinomas). The
average number of tumors found per lung was 10% of
thatseenincontrols. Theoriginalconclusionappliedthus
to a second experimental system.
Yet, another model system in which the effects of
oxygen on lung tumor development could be exam-
ined appearedtobethehamstermodelthatwasoriginal-
ly developed by Reznik-Schuller (69,70). Here, oxygen
hadadifferenteffect. Whilebeingtreatedwith thecar-
cinogen N-nitroso-diethylamine (DEN), hamsters ex-
posed to70% oxygendeveloped, within8weeks, multiple
lungtumorsofneuroendocrine cellorigin(71). Thiswas
the first time that this particular tumor had been pro-
duced in a reproducible way in experimental animals.
In man, neuroendocrine lung cancer is commonly
subdivided into carcinoid and small cell lung cancer
(72,73). Carcinoids are generally well-differentiated
tumorsthatrarelymetastasize; whereas, smallcelllung
cancer, whichconstitutessomefourthofallhumanlung
cancers, is highly malignant and metastasizes early.
The tumor usually responds well to initial treatment
withchemotherapeuticagents. Resistancethendevelops
rather soon, and the median survival time of patients
withdiagnosed smallcell cancerofthe lungisabout 12
months. Only5% to 10% ofallpatientssurvivefor3years
or more.
Epidemiological data link this particular tumor with
cigarettesmoking; thetumorisvirtuallyneverfoundin
nonsmokers. Additionalcontributingrisksareexposure
toradiation, asinuraniumminers, andchronicexposure
to asbestos fibers in the air.
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How then do we explain the findingthat a combina-
tion of hyperoxia and DEN would produce neuroen-
docrine lung cancer in hamsters? Neuroendocrine
cells have been identified in the lungs of many
species. The cells are comparatively rare in adult
lungs, but they occurin great abundance in fetal lungs
and immediately afterbirth (74,75). They are believed
to play a role in helping the lung to adapt to drastic
changesinpulmonaryoxygenlevelsthroughtheproduc-
tion of vasoactive substances as may occur during the
transition from intrauterine to extrauterine life. The
pulmonary neuroendocrine cells contain vasoactive
substances such as serotonin, bombesin, calcitonin or
neuron-specific enolase. When the oxygenation of the
lungchanges(underconditionsofhyperoxia orhypoxia)
the number ofcells also changes, as for example when
thelunggoesfromacomparativelyhypoxicenvironment
inuterotoanenvironmentofphysiologicaloxygentoxi-
city after birth (76-80). In patients suffering from
chronicobstructivelungdiseaseandinmanlivingathigh
altitudes,thenumberofneuroendocrinecellsinthelung
is also increased (81).
Conditions of oxygen imbalance in the lung may
thus altertheproliferativestatusofpulmonaryneuroen-
docrine cells and explain why, in hamsters exposed to
hyperoxia, tumorsdevelopinresponsetoDENadminis-
tration. Since the occurrence of neuroendocrine cell
tumors in man also appears to be linked to conditions
ofoxygenimbalanceinthelung(chronicobstructivelung
disease is found mostly in smokers), the availability of
thisnewanimalmodelofaspecifichumanlungdisease
should allow researchers to carry out important
mechanistic studies in the future.
Conclusions
The study of the lung response to toxic injury even-
tually should help topredict the development ofacute
and chronic lung disease from first principles. Unfor-
tunately, firstprinciplesaremuchhardertodevelopfor
thebiologic response thanforthebiotransfonnation and
activationoftoxicchemicals. Onoccasion, firstprinciples
derivedfromanalyzingthebiologicalresponse are suc-
cessful, at least in some systems. One such example
mightbethatinhibitionofproperreepithelialization of
a damaged alveolar wall will lead to the development
of fibrotic changes.
Inananalysisofotherexamplesitwasfoundthatwhat
was first believed to be a universal mechanism did not
necessarilyapplytoallcircumstances. Generaltargetcell
hyperplasiaandtheenhancementoftumordevelopment
areclearlyseparableeventsinmouselungandneednot
be linked to each other, as has been postulated for
numerousotherorgansandtissues. There appear tobe
speciesdifferencesintheresponseoflungtotoxicinjury,
asexemplifiedbythedifferentpatternsofcellprolifera-
tionobservedduringrecoveryinthelungsofmice, rats,
hamsters, and marmosets. Even more dramatic are the
observations that when rat lungs are exposed to a
potent carcinogen, oxygeninhibitstumordevelopment,
whereas in hamsters, hyperoxia together with a
systemicallyactingcarcinogenresultsinneuroendocrine
lungcancer, adiseasepreviouslynotinducedinthelungs
of experimental animals.
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